Literature DB >> 1254732

Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.

C R Kahn, K Megyesi, J Roth.   

Abstract

Nonsuppressible insulin-like activity soluble in acid ethanol (NSILA-s) is a well-characterized peptide derived from human serum which has previously been shown to have insulin-like bioactivity and react with both insulin and NSILA-s receptor sites in liver plasma membranes. In the present study we find that NSILA-s is also a potent competitive inhibitor of the insulin-degrading system of the liver plasma membrane. The most purified NSILA-s preparation tested was 20-fold more potent than insulin itself, and significant inhibition of insulin degradation occurred at concentrations of NSILA-s similar to those found in plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254732      PMCID: PMC436679          DOI: 10.1172/JCI108306

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor.

Authors:  K Megyesi; C R Kahn; J Roth; D M Neville; S P Nissley; R E Humbel; E R Froesch
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

2.  Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.

Authors:  K Megyesi; C R Kahn; J Roth; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

3.  Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites.

Authors:  K Megyesi; C R Kahn; J Roth; E R Froesch; R E Humbel; J Zapf; D M Neville
Journal:  Biochem Biophys Res Commun       Date:  1974-03-15       Impact factor: 3.575

4.  DNA synthesis in human fibroblasts: stimulation by insulin and by nonsuppressible insulin-like activity (NSILA-S).

Authors:  M M Rechler; J M Podskalny; I D Goldfine; C A Wells
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

5.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

6.  Isolation of an organ specific protein antigen from cell-surface membrane of rat liver.

Authors:  D M Neville
Journal:  Biochim Biophys Acta       Date:  1968-04-09

7.  Insulin degradation. X. Identification of insulin degrading activity of rat liver plasma membrane as glutathione-insulin transhydrogenase.

Authors:  P T Varandani
Journal:  Biochem Biophys Res Commun       Date:  1973-12-10       Impact factor: 3.575

8.  Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA.

Authors:  A Jakob; C Hauri; E R Froesch
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

9.  Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.

Authors:  A E Kitabchi; W C Duckworth; J S Brush; M Heinemann
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

  9 in total
  4 in total

1.  Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.

Authors:  A C Herington; A D Kuffer
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

Review 2.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

3.  Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.

Authors:  H P Guler; C Schmid; J Zapf; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Receptor-linked degradation of 125I-insulin is mediated by internalization in isolated rat hepatocytes.

Authors:  P Gorden; P Freychet; J L Carpentier; B Canivet; L Orci
Journal:  Yale J Biol Med       Date:  1982 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.